Reid Landes
Concepts (386)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 5 | 2024 | 359 | 1.460 |
Why?
| | Parkinson Disease | 4 | 2025 | 155 | 1.220 |
Why?
| | Radiation-Protective Agents | 4 | 2021 | 72 | 1.190 |
Why?
| | Gait Disorders, Neurologic | 4 | 2025 | 37 | 1.190 |
Why?
| | Sample Size | 3 | 2023 | 44 | 1.090 |
Why?
| | Random Allocation | 2 | 2024 | 285 | 0.990 |
Why?
| | Reward | 10 | 2013 | 115 | 0.880 |
Why?
| | Smoking | 8 | 2015 | 520 | 0.850 |
Why?
| | Radiation Injuries | 2 | 2023 | 110 | 0.840 |
Why?
| | Antipsychotic Agents | 4 | 2014 | 235 | 0.810 |
Why?
| | Impulsive Behavior | 9 | 2015 | 78 | 0.780 |
Why?
| | Opioid-Related Disorders | 6 | 2023 | 400 | 0.750 |
Why?
| | Heart Diseases | 1 | 2023 | 216 | 0.700 |
Why?
| | Heart | 7 | 2023 | 345 | 0.690 |
Why?
| | Models, Psychological | 3 | 2017 | 81 | 0.640 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 159 | 0.620 |
Why?
| | Oxygen | 5 | 2023 | 336 | 0.620 |
Why?
| | Clinical Trials as Topic | 2 | 2020 | 467 | 0.600 |
Why?
| | Toxicology | 1 | 2018 | 28 | 0.600 |
Why?
| | Animals | 25 | 2025 | 13505 | 0.580 |
Why?
| | Tobacco Use Disorder | 7 | 2015 | 171 | 0.580 |
Why?
| | Data Interpretation, Statistical | 4 | 2024 | 164 | 0.570 |
Why?
| | Humans | 64 | 2025 | 52483 | 0.570 |
Why?
| | Male | 56 | 2025 | 26761 | 0.540 |
Why?
| | Protons | 3 | 2023 | 70 | 0.510 |
Why?
| | Radiation Protection | 2 | 2013 | 47 | 0.500 |
Why?
| | Levodopa | 3 | 2025 | 45 | 0.480 |
Why?
| | Housing, Animal | 2 | 2025 | 18 | 0.470 |
Why?
| | Confidence Intervals | 3 | 2013 | 158 | 0.470 |
Why?
| | Social Behavior | 2 | 2012 | 74 | 0.460 |
Why?
| | Female | 49 | 2025 | 28171 | 0.460 |
Why?
| | Heart Defects, Congenital | 1 | 2020 | 619 | 0.450 |
Why?
| | Gait | 3 | 2025 | 88 | 0.450 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2012 | 146 | 0.450 |
Why?
| | Amphetamine-Related Disorders | 2 | 2012 | 93 | 0.450 |
Why?
| | Animal Welfare | 1 | 2013 | 7 | 0.430 |
Why?
| | Methamphetamine | 3 | 2012 | 198 | 0.430 |
Why?
| | Psychotic Disorders | 2 | 2014 | 139 | 0.420 |
Why?
| | Cognition Disorders | 5 | 2015 | 196 | 0.410 |
Why?
| | Guidelines as Topic | 1 | 2013 | 111 | 0.410 |
Why?
| | Motivation | 6 | 2019 | 282 | 0.410 |
Why?
| | Evidence-Based Practice | 1 | 2013 | 112 | 0.400 |
Why?
| | Smoking Cessation | 6 | 2015 | 315 | 0.390 |
Why?
| | Cosmic Radiation | 2 | 2023 | 38 | 0.380 |
Why?
| | Adult | 27 | 2024 | 14161 | 0.380 |
Why?
| | Intestine, Small | 3 | 2021 | 115 | 0.370 |
Why?
| | Behavior, Addictive | 2 | 2011 | 58 | 0.370 |
Why?
| | Proportional Hazards Models | 2 | 2014 | 443 | 0.370 |
Why?
| | Radiation Injuries, Experimental | 1 | 2012 | 81 | 0.360 |
Why?
| | Quality Improvement | 1 | 2013 | 226 | 0.360 |
Why?
| | Radiation, Ionizing | 4 | 2021 | 101 | 0.360 |
Why?
| | Herbicide Resistance | 1 | 2011 | 2 | 0.360 |
Why?
| | Shikimic Acid | 1 | 2011 | 4 | 0.360 |
Why?
| | Crops, Agricultural | 1 | 2011 | 7 | 0.360 |
Why?
| | Lethal Dose 50 | 3 | 2018 | 12 | 0.360 |
Why?
| | Spectrophotometry | 1 | 2011 | 32 | 0.360 |
Why?
| | Probability | 4 | 2018 | 172 | 0.360 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2012 | 168 | 0.350 |
Why?
| | Buprenorphine | 4 | 2023 | 151 | 0.350 |
Why?
| | Glycine | 1 | 2011 | 75 | 0.350 |
Why?
| | Survival Analysis | 1 | 2012 | 673 | 0.330 |
Why?
| | Cognition | 5 | 2019 | 331 | 0.330 |
Why?
| | Individuality | 1 | 2010 | 29 | 0.330 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2011 | 339 | 0.320 |
Why?
| | Psychometrics | 2 | 2010 | 230 | 0.320 |
Why?
| | Computer Simulation | 3 | 2020 | 290 | 0.320 |
Why?
| | Dementia | 4 | 2014 | 134 | 0.310 |
Why?
| | Choice Behavior | 5 | 2013 | 83 | 0.310 |
Why?
| | Metabolic Diseases | 2 | 2023 | 46 | 0.310 |
Why?
| | Central Nervous System Stimulants | 3 | 2008 | 206 | 0.300 |
Why?
| | Time Factors | 11 | 2017 | 2968 | 0.300 |
Why?
| | Satiation | 1 | 2008 | 8 | 0.300 |
Why?
| | Plant Extracts | 1 | 2011 | 194 | 0.300 |
Why?
| | Middle Aged | 25 | 2025 | 13028 | 0.290 |
Why?
| | Nicotine | 2 | 2009 | 180 | 0.290 |
Why?
| | Young Adult | 11 | 2023 | 4329 | 0.290 |
Why?
| | Nuclear Weapons | 2 | 2019 | 4 | 0.280 |
Why?
| | Executive Function | 3 | 2015 | 72 | 0.280 |
Why?
| | Quality Assurance, Health Care | 1 | 2008 | 149 | 0.280 |
Why?
| | Time Perception | 3 | 2017 | 28 | 0.270 |
Why?
| | Mice | 14 | 2025 | 5949 | 0.270 |
Why?
| | Health Behavior | 2 | 2020 | 257 | 0.270 |
Why?
| | Guideline Adherence | 1 | 2008 | 138 | 0.270 |
Why?
| | Mice, Inbred C57BL | 10 | 2025 | 1884 | 0.270 |
Why?
| | Rats | 7 | 2024 | 3220 | 0.260 |
Why?
| | Schizophrenia | 1 | 2008 | 254 | 0.260 |
Why?
| | Dose-Response Relationship, Radiation | 5 | 2023 | 184 | 0.260 |
Why?
| | DNA Methylation | 3 | 2022 | 592 | 0.250 |
Why?
| | Adipose Tissue | 2 | 2025 | 204 | 0.240 |
Why?
| | Quality of Life | 2 | 2022 | 879 | 0.240 |
Why?
| | Cocaine-Related Disorders | 3 | 2014 | 207 | 0.240 |
Why?
| | Antiparkinson Agents | 1 | 2025 | 24 | 0.240 |
Why?
| | Aged | 19 | 2025 | 10121 | 0.230 |
Why?
| | Decision Making | 5 | 2015 | 282 | 0.230 |
Why?
| | Adipose Tissue, Brown | 1 | 2025 | 44 | 0.230 |
Why?
| | Animals, Laboratory | 1 | 2024 | 6 | 0.230 |
Why?
| | Opiate Substitution Treatment | 3 | 2023 | 102 | 0.230 |
Why?
| | Rats, Inbred WKY | 1 | 2024 | 34 | 0.230 |
Why?
| | Exercise | 3 | 2023 | 547 | 0.230 |
Why?
| | Rats, Inbred SHR | 1 | 2024 | 42 | 0.230 |
Why?
| | Disease Progression | 2 | 2024 | 871 | 0.220 |
Why?
| | Temperature | 1 | 2025 | 183 | 0.220 |
Why?
| | Writing | 1 | 2024 | 45 | 0.220 |
Why?
| | Muscle Contraction | 1 | 2024 | 117 | 0.220 |
Why?
| | Lymphatic Vessels | 1 | 2024 | 55 | 0.220 |
Why?
| | Biological Factors | 1 | 2023 | 12 | 0.210 |
Why?
| | Anti-Asthmatic Agents | 1 | 2023 | 33 | 0.210 |
Why?
| | Radiation Dosage | 4 | 2021 | 163 | 0.210 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2020 | 509 | 0.210 |
Why?
| | Tai Ji | 1 | 2023 | 22 | 0.210 |
Why?
| | Heart Atria | 1 | 2023 | 63 | 0.210 |
Why?
| | Energy Metabolism | 1 | 2025 | 302 | 0.200 |
Why?
| | Feasibility Studies | 2 | 2023 | 406 | 0.200 |
Why?
| | Socioeconomic Factors | 3 | 2020 | 610 | 0.200 |
Why?
| | Metformin | 1 | 2023 | 76 | 0.200 |
Why?
| | Transcranial Magnetic Stimulation | 2 | 2013 | 72 | 0.200 |
Why?
| | Space Flight | 2 | 2019 | 32 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 1378 | 0.190 |
Why?
| | Models, Statistical | 3 | 2013 | 230 | 0.190 |
Why?
| | Severity of Illness Index | 2 | 2024 | 1026 | 0.190 |
Why?
| | Spleen | 2 | 2020 | 172 | 0.190 |
Why?
| | Lymphocytes | 1 | 2022 | 153 | 0.180 |
Why?
| | Duodenum | 1 | 2021 | 34 | 0.180 |
Why?
| | Reproducibility of Results | 2 | 2023 | 1229 | 0.180 |
Why?
| | Protein C | 1 | 2021 | 20 | 0.180 |
Why?
| | Social Class | 2 | 2012 | 94 | 0.180 |
Why?
| | Biomedical Research | 1 | 2024 | 256 | 0.180 |
Why?
| | Ions | 4 | 2023 | 32 | 0.180 |
Why?
| | Jejunum | 1 | 2021 | 55 | 0.180 |
Why?
| | Universities | 2 | 2024 | 175 | 0.180 |
Why?
| | Ileum | 1 | 2021 | 88 | 0.180 |
Why?
| | Odds Ratio | 3 | 2018 | 558 | 0.180 |
Why?
| | Hospitals, Veterans | 2 | 2013 | 110 | 0.180 |
Why?
| | Bayes Theorem | 2 | 2018 | 121 | 0.180 |
Why?
| | Chromosome Aberrations | 1 | 2022 | 297 | 0.170 |
Why?
| | Survivors | 2 | 2019 | 120 | 0.170 |
Why?
| | Weightlessness Simulation | 1 | 2020 | 22 | 0.170 |
Why?
| | Thymus Gland | 1 | 2020 | 41 | 0.170 |
Why?
| | Gamma Rays | 1 | 2020 | 49 | 0.170 |
Why?
| | Amitriptyline | 1 | 2020 | 13 | 0.170 |
Why?
| | Home Care Agencies | 1 | 2020 | 6 | 0.170 |
Why?
| | Aorta, Abdominal | 1 | 2020 | 39 | 0.170 |
Why?
| | Insulin Resistance | 1 | 2022 | 275 | 0.170 |
Why?
| | Fibromyalgia | 1 | 2020 | 16 | 0.170 |
Why?
| | Psychological Tests | 2 | 2017 | 49 | 0.160 |
Why?
| | Aged, 80 and over | 11 | 2019 | 3392 | 0.160 |
Why?
| | Adolescent | 10 | 2023 | 6739 | 0.160 |
Why?
| | Monte Carlo Method | 1 | 2020 | 87 | 0.160 |
Why?
| | Healthcare Disparities | 2 | 2014 | 299 | 0.160 |
Why?
| | Quality Indicators, Health Care | 1 | 2020 | 90 | 0.160 |
Why?
| | Hypertension | 1 | 2024 | 565 | 0.160 |
Why?
| | Asthma | 1 | 2023 | 316 | 0.160 |
Why?
| | Phenotype | 1 | 2022 | 789 | 0.160 |
Why?
| | Oxygen Radioisotopes | 1 | 2019 | 14 | 0.150 |
Why?
| | Adaptation, Psychological | 1 | 2020 | 230 | 0.150 |
Why?
| | Home Care Services | 1 | 2020 | 72 | 0.150 |
Why?
| | Arkansas | 8 | 2022 | 2028 | 0.150 |
Why?
| | Thigh | 1 | 2018 | 34 | 0.150 |
Why?
| | Analysis of Variance | 2 | 2017 | 554 | 0.150 |
Why?
| | User-Computer Interface | 1 | 2018 | 79 | 0.150 |
Why?
| | Weight Gain | 2 | 2022 | 240 | 0.140 |
Why?
| | Skin | 1 | 2021 | 422 | 0.140 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 490 | 0.140 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2018 | 107 | 0.140 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2017 | 38 | 0.140 |
Why?
| | Drug Monitoring | 2 | 2014 | 83 | 0.140 |
Why?
| | Gene Expression | 2 | 2019 | 618 | 0.130 |
Why?
| | Intention | 1 | 2017 | 48 | 0.130 |
Why?
| | Whole-Body Irradiation | 2 | 2021 | 127 | 0.130 |
Why?
| | Directive Counseling | 2 | 2014 | 23 | 0.130 |
Why?
| | Telephone | 2 | 2014 | 71 | 0.130 |
Why?
| | Myocardium | 1 | 2019 | 453 | 0.130 |
Why?
| | Depressive Disorder | 2 | 2009 | 334 | 0.130 |
Why?
| | United States | 5 | 2020 | 5192 | 0.130 |
Why?
| | Tomography, X-Ray Computed | 2 | 2019 | 1165 | 0.130 |
Why?
| | Body Weight | 2 | 2020 | 523 | 0.120 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 21 | 0.120 |
Why?
| | Gene Duplication | 1 | 2015 | 16 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 1 | 2017 | 187 | 0.120 |
Why?
| | Green Fluorescent Proteins | 1 | 2015 | 93 | 0.120 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2015 | 37 | 0.120 |
Why?
| | Students | 1 | 2017 | 228 | 0.120 |
Why?
| | Liver | 3 | 2023 | 1156 | 0.110 |
Why?
| | Conditioning, Operant | 1 | 2015 | 106 | 0.110 |
Why?
| | Hyperlipidemias | 1 | 2014 | 52 | 0.110 |
Why?
| | Educational Status | 4 | 2015 | 226 | 0.110 |
Why?
| | Alzheimer Disease | 2 | 2009 | 332 | 0.110 |
Why?
| | Hyperglycemia | 1 | 2014 | 88 | 0.110 |
Why?
| | Biofeedback, Psychology | 1 | 2013 | 18 | 0.110 |
Why?
| | Electric Stimulation | 1 | 2013 | 107 | 0.110 |
Why?
| | Medical Records | 1 | 2013 | 87 | 0.110 |
Why?
| | Databases, Factual | 2 | 2013 | 706 | 0.100 |
Why?
| | Pain | 2 | 2023 | 362 | 0.100 |
Why?
| | Eye Diseases | 1 | 2013 | 29 | 0.100 |
Why?
| | Sexual Behavior | 1 | 2014 | 128 | 0.100 |
Why?
| | Cluster Analysis | 1 | 2013 | 233 | 0.100 |
Why?
| | Physicians, Primary Care | 1 | 2013 | 46 | 0.100 |
Why?
| | Cross-Sectional Studies | 4 | 2024 | 1678 | 0.100 |
Why?
| | Cholesterol, LDL | 1 | 2013 | 43 | 0.100 |
Why?
| | Sex Characteristics | 1 | 2014 | 198 | 0.100 |
Why?
| | Japan | 3 | 2019 | 38 | 0.100 |
Why?
| | Diabetes Complications | 1 | 2013 | 122 | 0.100 |
Why?
| | Animal Experimentation | 1 | 2012 | 3 | 0.100 |
Why?
| | Longitudinal Studies | 3 | 2024 | 747 | 0.100 |
Why?
| | Internal-External Control | 1 | 2012 | 31 | 0.100 |
Why?
| | Internet | 1 | 2014 | 263 | 0.100 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2014 | 323 | 0.090 |
Why?
| | Aggression | 2 | 2011 | 50 | 0.090 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 192 | 0.090 |
Why?
| | Community Networks | 1 | 2012 | 50 | 0.090 |
Why?
| | Commodification | 1 | 2011 | 2 | 0.090 |
Why?
| | Treatment Outcome | 7 | 2018 | 5422 | 0.090 |
Why?
| | Herbicides | 1 | 2011 | 11 | 0.090 |
Why?
| | Qualitative Research | 1 | 2013 | 364 | 0.090 |
Why?
| | Veterans | 2 | 2018 | 583 | 0.090 |
Why?
| | Receptors, Steroid | 1 | 2010 | 20 | 0.090 |
Why?
| | Adolescent Behavior | 1 | 2011 | 106 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 1 | 2012 | 483 | 0.090 |
Why?
| | Education | 1 | 2010 | 40 | 0.090 |
Why?
| | Psychomotor Agitation | 1 | 2011 | 51 | 0.090 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 2010 | 78 | 0.080 |
Why?
| | Antibodies, Monoclonal | 2 | 2005 | 481 | 0.080 |
Why?
| | Clinical Competence | 1 | 2013 | 406 | 0.080 |
Why?
| | Meta-Analysis as Topic | 1 | 2010 | 40 | 0.080 |
Why?
| | Dexamethasone | 2 | 2010 | 438 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 2013 | 360 | 0.080 |
Why?
| | Memory, Short-Term | 1 | 2010 | 72 | 0.080 |
Why?
| | Blood Glucose | 1 | 2013 | 473 | 0.080 |
Why?
| | Aging | 1 | 2015 | 701 | 0.080 |
Why?
| | Marijuana Abuse | 1 | 2011 | 156 | 0.080 |
Why?
| | Extinction, Psychological | 1 | 2009 | 34 | 0.080 |
Why?
| | Mutation | 1 | 2015 | 1347 | 0.080 |
Why?
| | Logistic Models | 4 | 2014 | 925 | 0.080 |
Why?
| | Apolipoprotein E4 | 1 | 2009 | 22 | 0.080 |
Why?
| | Ophthalmic Solutions | 1 | 2009 | 20 | 0.080 |
Why?
| | Diphenhydramine | 1 | 2009 | 18 | 0.080 |
Why?
| | Anesthesia, Local | 1 | 2009 | 17 | 0.080 |
Why?
| | Soybean Proteins | 1 | 2010 | 162 | 0.080 |
Why?
| | Cornea | 1 | 2009 | 53 | 0.080 |
Why?
| | Multivariate Analysis | 3 | 2017 | 591 | 0.080 |
Why?
| | Epigenesis, Genetic | 2 | 2022 | 406 | 0.080 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 467 | 0.070 |
Why?
| | Anesthetics, Local | 1 | 2009 | 79 | 0.070 |
Why?
| | Health Care Surveys | 1 | 2008 | 177 | 0.070 |
Why?
| | Models, Biological | 1 | 2011 | 735 | 0.070 |
Why?
| | Analgesics, Opioid | 3 | 2023 | 590 | 0.070 |
Why?
| | Child | 4 | 2023 | 7248 | 0.070 |
Why?
| | Analgesics | 1 | 2008 | 107 | 0.070 |
Why?
| | Rabbits | 2 | 2023 | 375 | 0.070 |
Why?
| | Mental Competency | 1 | 2007 | 32 | 0.070 |
Why?
| | Sex Factors | 3 | 2015 | 727 | 0.060 |
Why?
| | Informed Consent | 1 | 2007 | 95 | 0.060 |
Why?
| | Antibody Affinity | 1 | 2005 | 9 | 0.060 |
Why?
| | Thermogenesis | 1 | 2025 | 29 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2008 | 488 | 0.060 |
Why?
| | Lymph | 1 | 2024 | 24 | 0.060 |
Why?
| | Faculty | 1 | 2024 | 74 | 0.060 |
Why?
| | Activities of Daily Living | 2 | 2020 | 182 | 0.060 |
Why?
| | Research Personnel | 1 | 2024 | 71 | 0.050 |
Why?
| | Neuropsychological Tests | 3 | 2011 | 338 | 0.050 |
Why?
| | Angiotensin II | 1 | 2024 | 162 | 0.050 |
Why?
| | Single-Blind Method | 2 | 2013 | 116 | 0.050 |
Why?
| | Mental Disorders | 1 | 2008 | 428 | 0.050 |
Why?
| | Program Evaluation | 1 | 2024 | 353 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2024 | 1478 | 0.050 |
Why?
| | Prefrontal Cortex | 2 | 2013 | 85 | 0.050 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 116 | 0.050 |
Why?
| | Token Economy | 2 | 2014 | 33 | 0.050 |
Why?
| | Cytogenetic Analysis | 1 | 2022 | 80 | 0.050 |
Why?
| | Combined Modality Therapy | 2 | 2014 | 639 | 0.050 |
Why?
| | Alendronate | 1 | 2002 | 24 | 0.050 |
Why?
| | Methadone | 1 | 2023 | 183 | 0.050 |
Why?
| | Risk Factors | 3 | 2019 | 3889 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 123 | 0.050 |
Why?
| | Primates | 1 | 2021 | 22 | 0.050 |
Why?
| | Macaca mulatta | 1 | 2021 | 92 | 0.050 |
Why?
| | Chromans | 1 | 2021 | 35 | 0.050 |
Why?
| | Immunoblotting | 1 | 2021 | 116 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 224 | 0.040 |
Why?
| | Vitamin E | 1 | 2021 | 77 | 0.040 |
Why?
| | Catecholamines | 1 | 2020 | 44 | 0.040 |
Why?
| | Drinking | 1 | 2020 | 43 | 0.040 |
Why?
| | Rats, Long-Evans | 1 | 2020 | 25 | 0.040 |
Why?
| | Interviews as Topic | 2 | 2012 | 275 | 0.040 |
Why?
| | Intestines | 1 | 2021 | 154 | 0.040 |
Why?
| | Intestinal Mucosa | 1 | 2021 | 224 | 0.040 |
Why?
| | Policy | 1 | 2020 | 27 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2002 | 235 | 0.040 |
Why?
| | Area Under Curve | 2 | 2015 | 180 | 0.040 |
Why?
| | Energy Intake | 1 | 2020 | 174 | 0.040 |
Why?
| | Genotype | 1 | 2021 | 566 | 0.040 |
Why?
| | Insulin | 1 | 2022 | 479 | 0.040 |
Why?
| | Heart Rate | 1 | 2021 | 318 | 0.040 |
Why?
| | Age Factors | 2 | 2015 | 1132 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2020 | 6607 | 0.040 |
Why?
| | DNA, Satellite | 1 | 2019 | 13 | 0.040 |
Why?
| | Centromere | 1 | 2019 | 13 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2020 | 183 | 0.040 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2019 | 90 | 0.040 |
Why?
| | Carbon | 1 | 2019 | 55 | 0.040 |
Why?
| | Osteoclasts | 1 | 2002 | 428 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 93 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 3 | 2010 | 1563 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2021 | 979 | 0.040 |
Why?
| | Methionine | 1 | 2019 | 136 | 0.040 |
Why?
| | Organ Size | 1 | 2018 | 228 | 0.040 |
Why?
| | Medicare | 1 | 2020 | 274 | 0.040 |
Why?
| | Psychological Theory | 1 | 2017 | 26 | 0.040 |
Why?
| | Pregnancy | 1 | 2025 | 2680 | 0.040 |
Why?
| | Resistance Training | 1 | 2018 | 101 | 0.040 |
Why?
| | Retroelements | 1 | 2017 | 13 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 2017 | 37 | 0.030 |
Why?
| | Emotions | 1 | 2019 | 174 | 0.030 |
Why?
| | Apoptosis | 2 | 2019 | 1119 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2017 | 69 | 0.030 |
Why?
| | Species Specificity | 1 | 2017 | 192 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2015 | 22 | 0.030 |
Why?
| | Genes | 1 | 2015 | 31 | 0.030 |
Why?
| | DNA Damage | 1 | 2017 | 305 | 0.030 |
Why?
| | Age Distribution | 1 | 2015 | 174 | 0.030 |
Why?
| | Pancreas | 1 | 2015 | 71 | 0.030 |
Why?
| | Exons | 1 | 2015 | 102 | 0.030 |
Why?
| | Rural Population | 1 | 2020 | 577 | 0.030 |
Why?
| | Antibody Specificity | 2 | 2005 | 36 | 0.030 |
Why?
| | Bone and Bones | 1 | 2018 | 494 | 0.030 |
Why?
| | Infant | 1 | 2023 | 3733 | 0.030 |
Why?
| | Risk Assessment | 1 | 2019 | 1327 | 0.030 |
Why?
| | Control Groups | 1 | 2013 | 9 | 0.030 |
Why?
| | Obesity | 1 | 2022 | 1162 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2005 | 312 | 0.030 |
Why?
| | Narcotic Antagonists | 1 | 2014 | 139 | 0.030 |
Why?
| | Residence Characteristics | 1 | 2014 | 159 | 0.030 |
Why?
| | Gambling | 1 | 2013 | 18 | 0.030 |
Why?
| | Tobacco Products | 1 | 2015 | 127 | 0.030 |
Why?
| | Motor Activity | 2 | 2005 | 223 | 0.030 |
Why?
| | Ophthalmology | 1 | 2013 | 33 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2014 | 293 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 804 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2013 | 288 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 990 | 0.020 |
Why?
| | Recurrence | 1 | 2014 | 672 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2013 | 179 | 0.020 |
Why?
| | Health Status Disparities | 1 | 2014 | 215 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2013 | 292 | 0.020 |
Why?
| | Videotape Recording | 1 | 2011 | 27 | 0.020 |
Why?
| | Verbal Behavior | 1 | 2011 | 33 | 0.020 |
Why?
| | Homes for the Aged | 1 | 2011 | 33 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2010 | 48 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2010 | 77 | 0.020 |
Why?
| | Midazolam | 1 | 2010 | 37 | 0.020 |
Why?
| | Noise | 1 | 2011 | 41 | 0.020 |
Why?
| | Response Elements | 1 | 2010 | 29 | 0.020 |
Why?
| | Sex Distribution | 1 | 2011 | 137 | 0.020 |
Why?
| | Substance Abuse Detection | 1 | 2010 | 89 | 0.020 |
Why?
| | Caseins | 1 | 2010 | 78 | 0.020 |
Why?
| | Income | 1 | 2010 | 102 | 0.020 |
Why?
| | Protein Transport | 1 | 2010 | 180 | 0.020 |
Why?
| | Nursing Homes | 1 | 2011 | 112 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2015 | 2279 | 0.020 |
Why?
| | Language | 1 | 2011 | 138 | 0.020 |
Why?
| | Nicotinic Agonists | 1 | 2009 | 56 | 0.020 |
Why?
| | Self Administration | 1 | 2009 | 91 | 0.020 |
Why?
| | Administration, Topical | 1 | 2009 | 61 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2009 | 84 | 0.020 |
Why?
| | Reaction Time | 1 | 2009 | 209 | 0.020 |
Why?
| | Regression Analysis | 1 | 2009 | 401 | 0.020 |
Why?
| | Self Concept | 1 | 2008 | 61 | 0.020 |
Why?
| | Patient Compliance | 1 | 2009 | 230 | 0.020 |
Why?
| | Internship and Residency | 1 | 2013 | 448 | 0.020 |
Why?
| | Audiovisual Aids | 1 | 2007 | 13 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2010 | 1132 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 944 | 0.020 |
Why?
| | Reading | 1 | 2007 | 73 | 0.020 |
Why?
| | Prevalence | 1 | 2009 | 1006 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2005 | 195 | 0.010 |
Why?
| | Behavior, Animal | 1 | 2005 | 185 | 0.010 |
Why?
| | Drug Overdose | 1 | 2005 | 163 | 0.010 |
Why?
| | Amphetamine | 1 | 2003 | 38 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2003 | 171 | 0.010 |
Why?
| | Prednisolone | 1 | 2002 | 56 | 0.010 |
Why?
| | Osteoporosis | 1 | 2002 | 162 | 0.010 |
Why?
| | Cell Survival | 1 | 2002 | 612 | 0.010 |
Why?
| | Bone Density | 1 | 2002 | 399 | 0.010 |
Why?
| | Bone Resorption | 1 | 2002 | 302 | 0.010 |
Why?
| | Osteoblasts | 1 | 2002 | 475 | 0.010 |
Why?
| | Brain | 1 | 2003 | 1323 | 0.010 |
Why?
|
|
Landes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|